ES2045945T3 - Forma de dosificacion para suministrar farmacos solubles o insolubles. - Google Patents

Forma de dosificacion para suministrar farmacos solubles o insolubles.

Info

Publication number
ES2045945T3
ES2045945T3 ES90914278T ES90914278T ES2045945T3 ES 2045945 T3 ES2045945 T3 ES 2045945T3 ES 90914278 T ES90914278 T ES 90914278T ES 90914278 T ES90914278 T ES 90914278T ES 2045945 T3 ES2045945 T3 ES 2045945T3
Authority
ES
Spain
Prior art keywords
dosage form
pharmaces
insoluble
soluble
supply soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914278T
Other languages
English (en)
Inventor
Atul Devdatt Ayer
Anthony L Kuczynski
Patrick S L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2045945T3 publication Critical patent/ES2045945T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UNA FORMA DE DOSIS QUE COMPRENDE MEDIOS GRANULADOS PARA LA ADMINISTRACION DE MEDICAMENTOS SOLUBLES O INDISOLUBLES A UN ANIMAL DE SANGRE CALIENTE.
ES90914278T 1989-09-05 1990-08-31 Forma de dosificacion para suministrar farmacos solubles o insolubles. Expired - Lifetime ES2045945T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/403,523 US5035897A (en) 1989-09-05 1989-09-05 Dosage form for delivering soluble or insoluble drugs

Publications (1)

Publication Number Publication Date
ES2045945T3 true ES2045945T3 (es) 1994-01-16

Family

ID=23596097

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914278T Expired - Lifetime ES2045945T3 (es) 1989-09-05 1990-08-31 Forma de dosificacion para suministrar farmacos solubles o insolubles.

Country Status (19)

Country Link
US (1) US5035897A (es)
EP (1) EP0490987B1 (es)
JP (1) JP2840446B2 (es)
KR (1) KR920703022A (es)
AT (1) ATE96309T1 (es)
AU (1) AU629053B2 (es)
CA (1) CA2024505C (es)
DE (1) DE69004265T2 (es)
DK (1) DK0490987T3 (es)
ES (1) ES2045945T3 (es)
FI (1) FI920957A0 (es)
GR (1) GR1001017B (es)
IE (1) IE62595B1 (es)
MX (1) MX164443B (es)
NO (1) NO920785L (es)
NZ (1) NZ235126A (es)
PT (1) PT95168B (es)
WO (1) WO1991003235A1 (es)
ZA (1) ZA906973B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
WO1993009763A1 (en) * 1991-11-15 1993-05-27 Isp Investments Inc. Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
EP1027888B1 (en) * 1999-02-10 2009-06-10 Pfizer Products Inc. Osmotic system for delivery of solid amorphous dispersions of drugs
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
AU783685B2 (en) * 1999-12-23 2005-11-24 Pfizer Products Inc. Hydrogel-driven drug dosage form
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
CA2395231C (en) 1999-12-23 2006-08-15 Pfizer Products Inc. Hydrogel-driven layered drug dosage form
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
US8778395B2 (en) 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
WO2019223753A1 (zh) * 2018-05-23 2019-11-28 上海汉都医药科技有限公司 活性药物成分的控释系统及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US2909462A (en) * 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (es) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4434153A (en) * 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery

Also Published As

Publication number Publication date
NZ235126A (en) 1993-03-26
JP2840446B2 (ja) 1998-12-24
PT95168A (pt) 1991-05-22
GR1001017B (el) 1993-03-31
GR900100658A (en) 1992-01-20
ATE96309T1 (de) 1993-11-15
ZA906973B (en) 1991-06-26
DE69004265T2 (de) 1994-02-24
NO920785D0 (no) 1992-02-28
EP0490987A1 (en) 1992-06-24
CA2024505A1 (en) 1991-03-06
EP0490987B1 (en) 1993-10-27
KR920703022A (ko) 1992-12-17
DE69004265D1 (de) 1993-12-02
WO1991003235A1 (en) 1991-03-21
AU6429990A (en) 1991-04-08
AU629053B2 (en) 1992-09-24
FI920957A7 (fi) 1992-03-04
MX164443B (es) 1992-08-13
FI920957A0 (fi) 1992-03-04
US5035897A (en) 1991-07-30
PT95168B (pt) 1997-06-30
JPH05500223A (ja) 1993-01-21
IE903167A1 (en) 1991-03-13
CA2024505C (en) 2000-06-27
DK0490987T3 (da) 1993-11-29
NO920785L (no) 1992-03-02
IE62595B1 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
PT95169A (pt) Forma de dosagem para administracao de glipizida hipoglicemica por via oral
IT1104643B (it) Sistema terapeutico in forma di cerotto o simile per la somministrazione di clonidina per via transdermica e procedimento per la sua preparazione
NL990001I1 (nl) Geneesmiddel, dat dipyridamol of modipamol en O-acetylsalicylzuur resp. fysiologisch verdraagbare zouten daarvan, bevat, werkwijze voor de bereiding daarvan en toepassing daarvan voor het bestrijden van thrombusvorming.
ES513357A0 (es) "un sistema terapeutico bajo la forma de un vendaje para administrar el medicamento".
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
MX164443B (es) Forma de dosis para distribuir drogas solubles o insolubles
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ES2054715T3 (es) Nuevos derivados de naftaleno y productos farmaceuticos antialergicos y antiinflamatorios.
ATE46444T1 (de) Rektale verabreichung von arzneimitteln mit hilfsmitteln.
ES277844Y (es) Una disposicion de punta de dosificacion para administrar una dosis de medicamento, alimentos, vitaminas o similares, a un paciente
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK400887D0 (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
FR2355502A1 (fr) Application a titre de medicaments d'un derive de la piperazine et de ses sels
SE8501312D0 (sv) Etoposide oral dosage form
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
FR2427822A1 (fr) Medicament pour le traitement des maladies circulatoires, a base de 5-methyl-7-dimethylamino-s-triazolo (1,5-a) pyrimidine
ES2096081T3 (es) Utilizacion de interleuquina 10 para la preparacion de medicamentos con una actividad inhibidora de tumores.
GB1254125A (en) Pharmaceutical composition suitable for the treatment of certain vascular diseases
DK160388D0 (da) Tert-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 og syreadditionssalte deraf til anvendelse som terapeutisk aktivt stof
SE8605216D0 (sv) Novel medicinal use
NO873805D0 (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
ES284095Y (es) Disposicion de canulas perfeccionada para la administracion terapeutica de medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 490987

Country of ref document: ES